Fjalland B, Christensen A V, Hyttel J
Naunyn Schmiedebergs Arch Pharmacol. 1977 Dec;301(1):5-9. doi: 10.1007/BF00501257.
The muscarinic receptor affinity of 27 psychotropic and 5 anticholinergic substances was examined in 2 in-vivo and 2 in-vitro models. A highly significant correlation was obtained between the effect of all compounds examined on the atropine sensitive binding of 3H-PrBCM and the effect in the conventional guinea-pig ileum preparation. Antagonism of oxotremorine induced tremors in mice by anticholinergics and neuroleptics was also significantly correlated to the corresponding data obtained in the in-vitro tests. Due to very low potency in the physostigmine induced mortality test in mice too few ED50 values were obtained to perform statistical comparisons. It is concluded, that the conventional guinea-pig ileum model and the 3h-prBCM binding model are equally predictive as tests for antimuscarinic properties. When in-vivo anticholinergic data for neuroleptics are used it must be considered that a possible dopamine receptor blockade may diminish the antimuscarinic effect of the substance.
在2种体内模型和2种体外模型中检测了27种精神药物和5种抗胆碱能物质的毒蕈碱受体亲和力。在所检测的所有化合物对3H-PrBCM的阿托品敏感结合的作用与在传统豚鼠回肠制备中的作用之间获得了高度显著的相关性。抗胆碱能药物和抗精神病药物对氧化震颤素诱发的小鼠震颤的拮抗作用也与体外试验中获得的相应数据显著相关。由于在毒扁豆碱诱发的小鼠死亡率试验中效力非常低,获得的半数有效剂量(ED50)值太少,无法进行统计学比较。得出的结论是,传统豚鼠回肠模型和3H-PrBCM结合模型作为抗毒蕈碱特性的测试具有同等的预测性。当使用抗精神病药物的体内抗胆碱能数据时,必须考虑到可能的多巴胺受体阻断可能会减弱该物质的抗毒蕈碱作用。